NEWSROOM

Insights, events, and firm news for life sciences, pharmaceutical, chemical, and technology innovators.

BEYOND THE 20-YEAR PATENT: MAKING REGULATORY EXCLUSIVITY WORK FOR YOUR ASSET

Patents may last 20 years on paper, but real market protection for a drug or biologic depends on how you combine patent terms, extensions, and US/EU regulatory exclusivity. This article explains the key building blocks in plain language for life sciences teams.

Read More